{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:56:33Z","timestamp":1762505793827},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T00:00:00Z","timestamp":1310169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s11102-011-0325-0","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T17:15:15Z","timestamp":1310145315000},"page":"342-349","source":"Crossref","is-referenced-by-count":11,"title":["Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation"],"prefix":"10.1007","volume":"15","author":[{"given":"Luis V.","family":"Syro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie L.","family":"Sundsbak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd W.","family":"Scheithauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo A.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M.","family":"Heyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge I.","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Rotondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio P. A.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalman","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusica","family":"Babovic-Vuksanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,9]]},"reference":[{"key":"325_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321\u2013337","journal-title":"Annu Rev Med"},{"issue":"2","key":"325_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres VE, Harris PC (2009) Autosomal dominant polycystic kidney disease: the last 3\u00a0years. Kidney Int 76(2):149\u2013168","journal-title":"Kidney Int"},{"issue":"24","key":"325_CR3","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: acromegaly. N Eng J Med 355(24):2558\u20132573","journal-title":"N Eng J Med"},{"issue":"11","key":"325_CR4","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1172\/JCI39375","volume":"119","author":"S Melmed","year":"2009","unstructured":"Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119(11):3189\u20133202. doi: 10.1172\/JCI3937539375","journal-title":"J Clin Invest"},{"issue":"25\u201326","key":"325_CR5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1024\/0369-8394.91.25.1123","volume":"91","author":"R Fajfr","year":"2002","unstructured":"Fajfr R, Muller B, Diem P (2002) Hypophyseal incidentaloma in a patient with autosomal dominant polycystic kidney disease. Praxis 91(25\u201326):1123\u20131126","journal-title":"Praxis"},{"key":"325_CR6","unstructured":"Kannabiran M, Singh V, Grewal S (2006) Acromegaly presenting as psychotic disorder in a family with familial autosomal dominant polycystic kidney disease. German J Psychiatry 9:136\u2013138. http:\/\/www.gjpsy.uni-goettingen.de\/gjp-article-kannabiran.pdf"},{"issue":"7","key":"325_CR7","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","volume":"18","author":"S Rossetti","year":"2007","unstructured":"Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC (2007) Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18(7):2143\u20132216. doi: 10.1681\/ASN.2006121387","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"325_CR8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","volume":"75","author":"S Rossetti","year":"2009","unstructured":"Rossetti S, Kubly VJ, Consugar MB, Hopp K, Roy S, Horsley SW, Chauveau D, Rees L, Barratt TM, van\u2019t Hoff WG, Niaudet P, Torres VE, Harris PC (2009) Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int 75(8):848\u2013855. doi: 10.1038\/ki.2008.686","journal-title":"Kidney Int"},{"issue":"42","key":"325_CR9","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","volume":"103","author":"NS Pellegata","year":"2006","unstructured":"Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J, Atkinson MJ (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103(42):15558\u201315563. doi: 10.1073\/pnas.0603877103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"325_CR10","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1210\/jc.2006-2394","volume":"92","author":"RA Toledo","year":"2007","unstructured":"Toledo RA, Lourenco DM Jr, Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB, Toledo SP, Dahia PL (2007) Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. J Clin Endocrinol Metab 92(5):1934\u20131937. doi: 10.1210\/jc.2006-2394","journal-title":"J Clin Endocrinol Metab"},{"issue":"5777","key":"325_CR11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","volume":"312","author":"O Vierimaa","year":"2006","unstructured":"Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312(5777):1228\u20131230. doi: 10.1126\/science.1126100","journal-title":"Science"},{"issue":"1","key":"325_CR12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","volume":"68","author":"P Ruggenenti","year":"2005","unstructured":"Ruggenenti P, Remuzzi A, Ondei P, Fasolini G, Antiga L, Ene-Iordache B, Remuzzi G, Epstein FH (2005) Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int 68(1):206\u2013216","journal-title":"Kidney Int"},{"issue":"3","key":"325_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tem.2009.12.003","volume":"21","author":"A Ben-Shlomo","year":"2010","unstructured":"Ben-Shlomo A, Melmed S (2010) Pituitary somatostatin receptor signaling. Trends Endocrinol Metab 21(3):123\u2013133. doi: 10.1016\/j.tem.2009.12.003","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"325_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","volume":"20","author":"YC Patel","year":"1999","unstructured":"Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20(3):157\u2013198. doi: 10.1006\/frne.1999.0183","journal-title":"Front Neuroendocrinol"},{"issue":"4","key":"325_CR15","first-page":"427","volume":"16","author":"T Reisine","year":"1995","unstructured":"Reisine T, Bell GI (1995) Molecular biology of somatostatin receptors. Endocr Rev 16(4):427\u2013442","journal-title":"Endocr Rev"},{"issue":"4","key":"325_CR16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1172\/JCI119225","volume":"99","author":"I Shimon","year":"1997","unstructured":"Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD, Melmed S (1997) Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 99(4):789\u2013798","journal-title":"J Clin Invest"},{"issue":"8","key":"325_CR17","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1210\/jc.2005-0132","volume":"90","author":"M Filopanti","year":"2005","unstructured":"Filopanti M, Ronchi C, Ballare E, Bondioni S, Lania AG, Losa M, Gelmini S, Peri A, Orlando C, Beck-Peccoz P, Spada A (2005) Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly. J Clin Endocrinol Metab 90(8):4824\u20134828","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"325_CR18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jc.79.3.724","volume":"79","author":"Y Greenman","year":"1994","unstructured":"Greenman Y, Melmed S (1994) Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab 79(3):724\u2013729","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"325_CR19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/jcp.2005.026914","volume":"59","author":"E Thodou","year":"2006","unstructured":"Thodou E, Kontogeorgos G, Theodossiou D, Pateraki M (2006) Mapping of somatostatin receptor types in GH or\/and PRL producing pituitary adenomas. J Clin Pathol 59(3):274\u2013279. doi: 10.1136\/jcp.2005.026914","journal-title":"J Clin Pathol"},{"issue":"5","key":"325_CR20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000054651","volume":"73","author":"G Tulipano","year":"2001","unstructured":"Tulipano G, Bonfanti C, Milani G, Billeci B, Bollati A, Cozzi R, Maira G, Murphy WA, Poiesi C, Turazzi S, Giustina A (2001) Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro. Neuroendocrinology 73(5):344\u2013351","journal-title":"Neuroendocrinology"},{"issue":"3","key":"325_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1385\/ENDO:20:3:265","volume":"20","author":"I Shimon","year":"2003","unstructured":"Shimon I (2003) Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs. Endocrine 20(3):265\u2013269. doi: 10.1385\/ENDO:20:3:265","journal-title":"Endocrine"},{"issue":"1","key":"325_CR22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/eje.1.02313","volume":"156","author":"GF Taboada","year":"2007","unstructured":"Taboada GF, Luque RM, Bastos W, Guimaraes RF, Marcondes JB, Chimelli LM, Fontes R, Mata PJ, Filho PN, Carvalho DP, Kineman RD, Gadelha MR (2007) Quantitative analysis of somatostatin receptor subtype (SSTR1\u20135) gene expression levels in somatotropinomas and non-functioning pituitary adenomas. Eur J Endocrinol 156(1):65\u201374. doi: 10.1530\/eje.1.02313","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"325_CR23","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1530\/eje.1.02350","volume":"156","author":"J Hoek van der","year":"2007","unstructured":"van der Hoek J, Lamberts SW, Hofland LJ (2007) Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas. Eur J Endocrinol 156(Suppl 1):S45\u2013S51. doi: 10.1530\/eje.1.02350","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"325_CR24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","volume":"94","author":"S Melmed","year":"2009","unstructured":"Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94(5):1509\u20131517","journal-title":"J Clin Endocrinol Metab"},{"key":"325_CR25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000094315","volume":"35","author":"MD Bronstein","year":"2006","unstructured":"Bronstein MD (2006) Acromegaly molecular expression of somatostatin receptor subtypes and treatment outcome. Frontiers Horm Res 35:129\u2013134","journal-title":"Frontiers Horm Res"},{"issue":"4","key":"325_CR26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11102-009-0175-1","volume":"12","author":"AP Casarini","year":"2009","unstructured":"Casarini AP, Jallad RS, Pinto EM, Soares IC, Nonogaki S, Giannella-Neto D, Musolino NR, Alves VA, Bronstein MD (2009) Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment. Pituitary 12(4):297\u2013303. doi: 10.1007\/s11102-009-0175-1","journal-title":"Pituitary"},{"issue":"1","key":"325_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1009930223314","volume":"2","author":"AJ Lely van der","year":"1999","unstructured":"van der Lely AJ, de Herder WW, Lamberts SW (1999) New medical treatment for acromegaly. Pituitary 2(1):89\u201392","journal-title":"Pituitary"},{"issue":"Suppl 1","key":"325_CR28","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.dld.2003.11.022","volume":"36","author":"G Vitale","year":"2004","unstructured":"Vitale G, Pivonello R, Ferone D, De Martino MC, Auriemma RS, Caraglia M, Abbruzzese A, Lombardi G, Colao A (2004) The role of somatostatin receptors in the medical treatment of acromegaly. Dig Liver Dis 36(Suppl 1):S55\u2013S59","journal-title":"Dig Liver Dis"},{"issue":"8","key":"325_CR29","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1210\/jc.86.8.3809","volume":"86","author":"E Ballare","year":"2001","unstructured":"Ballare E, Persani L, Lania AG, Filopanti M, Giammona E, Corbetta S, Mantovani S, Arosio M, Beck-Peccoz P, Faglia G, Spada A (2001) Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment. J Clin Endocrinol Metab 86(8):3809\u20133814","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"325_CR30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2215\/CJN.05380709","volume":"5","author":"A Caroli","year":"2010","unstructured":"Caroli A, Antiga L, Cafaro M, Fasolini G, Remuzzi A, Remuzzi G, Ruggenenti P (2010) Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide. Clin J Am Soc Nephrol 5(5):783\u2013789. doi: 10.2215\/CJN.05380709","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"325_CR31","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","volume":"21","author":"MC Hogan","year":"2010","unstructured":"Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR 3rd, Rossetti S, Harris PC, LaRusso NF, Torres VE (2010) Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol 21(6):1052\u20131061. doi: 10.1681\/ASN.2009121291","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"325_CR32","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","volume":"137","author":"L Keimpema van","year":"2009","unstructured":"van Keimpema L, Nevens F, Vanslembrouck R, van Oijen MG, Hoffmann AL, Dekker HM, de Man RA, Drenth JP (2009) Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology 137(5):1661\u20131668. doi: 10.1053\/j.gastro.2009.07.052 e1661\u2013e1662","journal-title":"Gastroenterology"},{"issue":"2","key":"325_CR33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.ki.5002229","volume":"72","author":"E Parker","year":"2007","unstructured":"Parker E, Newby LJ, Sharpe CC, Rossetti S, Streets AJ, Harris PC, O\u2019Hare MJ, Ong AC (2007) Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras\/Raf signalling system. Kidney Int 72(2):157\u2013165. doi: 10.1038\/sj.ki.5002229","journal-title":"Kidney Int"},{"issue":"5","key":"325_CR34","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1210\/jc.2010-2721","volume":"96","author":"R Manara","year":"2011","unstructured":"Manara R, Maffei P, Citton V, Rizzati S, Bommarito G, Ermani M, Albano I, Della Puppa A, Carollo C, Pavesi G, Scanarini M, Ceccato F, Sicolo N, Mantero F, Scaroni C, Martini C (2011) Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature. J Clin Endocrinol Metab 96(5):1292\u20131300. doi: 10.1210\/jc.2010-2721","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"325_CR35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/geno.1996.0596","volume":"38","author":"R Sandford","year":"1996","unstructured":"Sandford R, Sgotto B, Burn T, Brenner S (1996) The tuberin (TSC2), autosomal dominant polycystic kidney disease (PKD1), and somatostatin type V receptor (SSTR5) genes form a synteny group in the Fugu genome. Genomics 38(1):84\u201386. doi: 10.1006\/geno.1996.0596","journal-title":"Genomics"},{"issue":"5","key":"325_CR36","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1055-9965.EPI-08-0893","volume":"18","author":"M Johansson","year":"2009","unstructured":"Johansson M, McKay JD, Wiklund F, Rinaldi S, Hallmans G, Balter K, Adami HO, Gronberg H, Stattin P, Kaaks R (2009) Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 18(5):1644\u20131650. doi: 10.1158\/1055-9965.EPI-08-0893","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"325_CR37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.mp.4001049","volume":"7","author":"M Nyegaard","year":"2002","unstructured":"Nyegaard M, Borglum AD, Bruun TG, Collier DA, Russ C, Mors O, Ewald H, Kruse TA (2002) Novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene associated with bipolar affective disorder. Mol Psychiatry 7(7):745\u2013754. doi: 10.1038\/sj.mp.4001049","journal-title":"Mol Psychiatry"},{"key":"325_CR38","doi-asserted-by":"crossref","unstructured":"Li D, Tanaka M, Brunicardi FC, Fisher WE, Gibbs RA, Gingras MC (2011) Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival. Cancer. doi: 10.1002\/cncr.25858","DOI":"10.1002\/cncr.25858"},{"issue":"1","key":"325_CR39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11060-009-0048-5","volume":"98","author":"W Hassaneen","year":"2010","unstructured":"Hassaneen W, Cahill DP, Fuller GN, Levine NB (2010) Immunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma. J Neurooncol 98(1):151\u2013152. doi: 10.1007\/s11060-009-0048-5","journal-title":"J Neurooncol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-011-0325-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-011-0325-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-011-0325-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T06:08:12Z","timestamp":1559369292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-011-0325-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1007\/s11102-011-0325-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,9]]}}}